期刊文献+

21号染色体上胎儿特异性基因SNP位点杂合率测定及意义 被引量:1

Detection and significance of heterozygote frequencies of SNP loci in chromosome 21 from placental mRNA
下载PDF
导出
摘要 目的检测中国人群中21号染色体上胎儿特异性基因单核苷酸多态性(SNP)位点的杂合率,为无创诊断唐氏综合征(DS)提供依据。方法分别检测89例孕妇(孕妇组)分娩前后的基因表达水平,并以100例年龄匹配的健康女性作为对照组,选择胎儿特异性基因;通过多重连接探针扩增技术(MLPA)检测特异性基因mRNA-SNP位点的状态,计算胎儿特异性基因mRNA-SNP位点的杂合率。结果 PLAC4和COL6A2基因表达量在孕妇组分娩前均显著高于分娩后和对照组(P均<0.05),故确定PLAC4和COL6A2作为研究对象;本研究对象mRNA-SNP杂合率不同于NCBI,尤以rs76461221,rs59066201及rs1044598位点为著。结论不同人群间SNP杂合率具有极大差异,临床可采用MLPA半定量检测孕妇外周血中胎儿游离RNA无创诊断DS。 Objective To investigate the heterozygote frequencies of single nucleotide polymorphism(SNP) loci from placental mRNA in the Chinese, so to find the fit SNP loci for noninvasive prenatal diagnosis of Down's syndrome. Methods The concentrations of placental expressed genes in 89 healthy pregnant (pregnant group)pre-and post-delivery were de-tected, and 100 non-pregnant individuals(control group)were chosen as control, then the fetal specificity genes were se- lected. Then the states of SNP loci of placental mRNA were detected by multiplex ligation-dependent probe amplification (MLPA)to calculate the heterozygote frequencies. Results The expressed levels of PLACA and COL6A2 in pre-delivery pregnant group were significantly higher than those in post-delivery pregnant group and control group ( both P 〈 0.05 ), so the PLACA and COL6A2 were chosen_ as the interested objects. The SNP loci of placental mRNA was different from NCBI, especially for rs76461221, rs59066201 and rs1044598. Conclusion The heterozygote frequencies of SNPs are different in different races of people. This kind of a semiquantitative MLPA method can be carried out for noninvasive prenatal diagno- sis of Down~ syndrome in clinic.
出处 《山东医药》 CAS 2012年第27期20-22,共3页 Shandong Medical Journal
基金 广东省科技厅政府特定任务项目(2011B061200045) 广州医学院博士启动基金资助项目(L95042)
关键词 唐氏综合征 无创性产前诊断 多重连接探针扩增技术 单核苷酸多态性 Down's syndrome noninvasive prenatal diagnosis multiplex ligation-dependent probe amplification sin-gle nueleotide polymorphism
  • 相关文献

参考文献15

  • 1Wright CF, Burton H. The use of cell-free fetal nucleic acids in ma- ternal blood for non-invasive prenatal diagnosis [ J ]. Hum Reprod Update, 2009,15( 1 ) :139-151.
  • 2Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagno- sis of fetal chromosomal aneuploidy by massively parallel genomic se- quencing of DNA in maternal plasma [ J ]. Proc Natl Acad Sci U S A, 2008,105 (51) :20458-20463.
  • 3Lun FMF, Tsui NBY, Chan KCA, et al. Noninvasive prenatal diag- nosis of monogenic diseases by digital size selection and relative mu- tation dosage on DNA in matemal plasma[ J]. Proc Natl Acad Sei U S A, 2008,105(50) :19920-19925.
  • 4Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection [J]. Nat Med, 2007,13(2) :218-223.
  • 5Schouten JP, Mcelgunn CJ, Waaijer R, et al. Relative quantifica- tion of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification [ J ]. Nucleic Acids Res, 2002,30 ( 12 ) : e57.
  • 6Ng EKO, Tsui NBY, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma[ J]. Proe Natl Acad Sci U S A, 2003,100(8) :4748-4753.
  • 7Mavrou A, Kouvidi E, Antsaklis A, et al. Identification of nucleat- ed red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications [ J ]. Prcnat Di- agn, 2007,27(2) :150-153.
  • 8Bianchi DW, Simpson JL, Jackson LG, et al. Fetal gender and ane- uploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study [ J ]. Prcnat Diagn, 2002,22 ( 7 ) : 609- 615.
  • 9Donaghue C, Mann K, Doeherty Z, et al. Detection of mosaieism for primary trisomies in prenatal samples by QFPCR and karyotype a- nalysis[ J]. Prenat Diagn, 2005,25 ( 1 ) :65-72.
  • 10Ciriglian V, Voglino G, Caadas MP, et al. Rapid prenatal diagno- sis of common chromosome aneuploidies by QF-PCR. Assessment on 18,000 consecutive clinical samples[ J ]. Mol Hum Reprod, 2004, 10( 11 ) :839-846.

同被引文献18

  • 1Stumm M, Wegner RD, Bloechle M, et al. Interphase M- FISH applications using commercial probes in prenatal and PGD diagnostics[J].Cytogenet Genome Res,2006,114 (3-4) : 296-301.
  • 2Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency:ultrasound screening for chromosomal defects in first trimester of pregnancy[J].BMJ,1992,304 (6831 ) :867- 869.
  • 3中华人民共和国卫生行业标准.胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准(第1部分):中孕期母血清学产前筛查[s].北京:中国标准出版社,2010:1-9.
  • 4Wald NJ, Rodeck C, Hackshaw AK, et al. SURUSS in perspective[J].BJOG,2004,111 (6) : 521-531.
  • 5Boormans EM, Birnie E, Wildsehut HI,et al. Multiplex ligation-dependent probe amplification versus karyotyping in prenatal diagnosis: the M.A.K.E.study[J].BMC Pregnancy Childbirth,2008,8:18.
  • 6Wright CF, Burton H.The use of cell-free fetal nucleic acids in maternal blood for non. invasive prenatal diagnosis[J].Hum Reprod Update,2009,15(1):139- l 51.
  • 7Chiu RWK,Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma[J]. Proc Natl Acad Sci U S A,2008,105(51):20458-20463.
  • 8Lun FMF, Tsui NBY, Chan KCA, et al.Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative rnuration dosage on DNA irt maternal plasma[J].Proc Natl Acad Sci U S A,2008,105(50): 19920-19925.
  • 9Poon LL,Leung TN,Lau TK,et al.Presence of fetal RNA in maternal plasma[J]. Clin Chem,2000,46( 11): 1832-1834.
  • 10Go AT, Visser A.44 single-nueleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21[J]. Clin Chem, 2007,53(12) :2223-2224.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部